Weed (BUDZ) Other Non Operating Income (2017 - 2026)
Weed's (BUDZ) quarterly Other Non Operating Income came in at -$11301.0 in Q1 2026, down 97.64% year-on-year from -$478660.1 in Q1 2025, and up 51.53% quarter-over-quarter from -$23314.0 in Q4 2025.
Weed (BUDZ) Other Non Operating Income (2017 - 2026) Analysis & Trends
Weed's Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$11301.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 97.64% year-over-year to -$11301.0 in Q1 2026; TTM through Mar 2026 was -$47349.0, a 340.56% decrease from a year earlier, with the FY2025 full-year figure at -$44494.0, down 326.14% from the prior year.
- Other Non Operating Income advanced to -$11301.0 in Q1 2026 per BUDZ's latest filing, from -$23314.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $973072.0 in Q3 2023 and bottomed at -$1.1 million in Q4 2023.
- The 5-year median for Other Non Operating Income is -$7016.0 (2025), against an average of -$15407.2.
- Across the five-year window, Other Non Operating Income sank 7290.16% in 2022 and soared 3450.11% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at -$567564.0 in 2022, then tumbled by 101.86% to -$1.1 million in 2023, then surged by 99.5% to -$5762.0 in 2024, then tumbled by 304.62% to -$23314.0 in 2025, then jumped by 51.53% to -$11301.0 in 2026.
- Per Business Quant, the three latest BUDZ Other Non Operating Income figures stand at -$11301.0 (Q1 2026), -$23314.0 (Q4 2025), and -$7016.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,301.00 |
| Dec 31, 2025 | -23,314.00 |
| Sep 30, 2025 | -7,016.00 |
| Mar 31, 2025 | -5,718.00 |
| Dec 31, 2024 | -5,762.00 |
| Sep 30, 2024 | -3,238.00 |
| Jun 30, 2024 | 34,401.00 |
| Mar 31, 2024 | -599.00 |
| Dec 31, 2023 | -1.15 Mn |
| Sep 30, 2023 | 973,072.00 |
| Mar 31, 2023 | -13,106.00 |
| Dec 31, 2022 | -567,564.00 |
| Sep 30, 2022 | -29,046.00 |
| Jun 30, 2022 | 633,610.00 |
| Mar 31, 2022 | -59,831.00 |
| Dec 31, 2021 | -7,680.00 |
| Sep 30, 2021 | -3,415.00 |
| Jun 30, 2021 | -20,151.00 |
| Mar 31, 2021 | -16,058.00 |
| Dec 31, 2020 | -4,592.00 |